Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion.

Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Zéni F, Pozzetto B, McNicol A, Garraud O, Cognasse F.

Clin Immunol. 2012 Dec;145(3):189-200. doi: 10.1016/j.clim.2012.09.004. Epub 2012 Sep 21.

PMID:
23108090
2.

LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand.

Damien P, Cognasse F, Eyraud MA, Arthaud CA, Pozzetto B, Garraud O, Hamzeh-Cognasse H.

BMC Immunol. 2015 Jan 31;16:3. doi: 10.1186/s12865-015-0067-2.

3.

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS.

J Immunol. 2000 Nov 15;165(10):5780-7.

4.

Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets.

Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Pozzetto B, McNicol A, Garraud O.

Br J Haematol. 2008 Apr;141(1):84-91. doi: 10.1111/j.1365-2141.2008.06999.x. Epub 2008 Feb 12.

PMID:
18279456
5.
7.

Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.

Sprong T, van der Ley P, Steeghs L, Taw WJ, Verver-Janssen TJ, Netea MG, van der Meer JW, van Deuren M.

Eur Cytokine Netw. 2002 Oct-Dec;13(4):411-7.

8.

Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates.

Levy E, Xanthou G, Petrakou E, Zacharioudaki V, Tsatsanis C, Fotopoulos S, Xanthou M.

Pediatr Res. 2009 Aug;66(2):179-84. doi: 10.1203/PDR.0b013e3181a9f41b.

PMID:
19390489
9.

R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.

Huber M, Kalis C, Keck S, Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Beutler B, Galanos C, Freudenberg MA.

Eur J Immunol. 2006 Mar;36(3):701-11.

10.

Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes.

Gudbrandsdottir S, Hasselbalch HC, Nielsen CH.

J Immunol. 2013 Oct 15;191(8):4059-67. doi: 10.4049/jimmunol.1201103. Epub 2013 Sep 18.

11.

Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass.

Hadley JS, Wang JE, Michaels LC, Dempsey CM, Foster SJ, Thiemermann C, Hinds CJ.

Shock. 2007 May;27(5):466-73.

PMID:
17438450
13.
14.

Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro.

Stopinšek S, Ihan A, Wraber B, Terčelj M, Salobir B, Rylander R, Simčič S.

Int Immunopharmacol. 2011 Aug;11(8):939-47. doi: 10.1016/j.intimp.2011.02.006. Epub 2011 Feb 15.

PMID:
21329777
15.

In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk.

Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM.

J Appl Physiol (1985). 2007 Jan;102(1):429-33. Epub 2006 Aug 17.

PMID:
16916914
16.

Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells.

Chung SH, Kweon MN, Lee HK, Choi SI, Yang JY, Kim EK.

Exp Eye Res. 2009 Jan;88(1):49-56. doi: 10.1016/j.exer.2008.09.017. Epub 2008 Oct 9.

PMID:
18951893
17.

siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells.

Lei M, Jiao H, Liu T, Du L, Cheng Y, Zhang D, Hao Y, Man C, Wang F.

Appl Microbiol Biotechnol. 2011 Oct;92(1):115-24. doi: 10.1007/s00253-011-3371-7. Epub 2011 Jun 24.

PMID:
21701985
18.

Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.

Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K.

Clin Exp Immunol. 2005 Aug;141(2):270-8.

19.

Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.

Dueñas AI, Aceves M, Orduña A, Díaz R, Sánchez Crespo M, García-Rodríguez C.

Int Immunol. 2006 May;18(5):785-95. Epub 2006 Mar 30.

PMID:
16574669
20.

Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.

Tsujimoto H, Ono S, Majima T, Efron PA, Kinoshita M, Hiraide H, Moldawer LL, Mochizuki H.

Clin Immunol. 2006 May;119(2):180-7. Epub 2006 Mar 6.

PMID:
16517212

Supplemental Content

Support Center